We have selected three organ type cancers with higher percentage of changes in CIP2A including lung squamous cell carcinoma, ovarian serous cystadenocarcinoma and Head and Neck squamous cell carcinoma in the context of clinical attributions and tabulated the changes in CIP2A (KIAA1524) gene. This evidence concerns the gene CIP2A and head and neck squamous cell carcinoma.